131I is administered as halide to treat hyperthyroidism and thyroid cancer, and may potentially be used to treat other tumors expressing the sodium iodide symporter (NIS, the transporter of iodide into the thyroid follicular cells) [1–3]. Here, SLC5A5 is linked to thyroid gland carcinoma.